VALIDATION OF THE SPECTROFOTOMETRIC METHOD FOR THE DETERMINATION OF QUANTITATIVE COMPOSITION OF S-2,6-DIAGENOXIC ACID OF 3-METHYL-1,2,4-TRIAZOLYL- 5-THIOACETATE

Authors

  • Kucherenko Lyudmila Ivanovna Department of Pharmaceutical Chemistry, Zaporizhia State Medical University, Zaporizhia, Ukraine http://orcid.org/0000-0002-5274-9676
  • BIDNENKO OLEKSANDR SERGEEVICH Department of Pharmaceutical Chemistry, Zaporizhia State Medical University, Zaporizhia, Ukraine http://orcid.org/0000-0003-2229-0232
  • Khromylova Olga Vladimirovna Department of Pharmaceutical Chemistry, Zaporizhia State Medical University, Zaporizhia, Ukraine http://orcid.org/0000-0001-8020-9952

DOI:

https://doi.org/10.22159/ajpcr.2018.v11i9.26684

Keywords:

Ischemic heart disease, Spectrophotometry, Quantitation, Validation, (S)-2, 6-diaminohexanoic acid 3-methyl-1, 2, 4-triazolyl-5-thioacetate

Abstract

Objective: The aim of the work was to determine the validation characteristics for the designed procedure for quantitation of the (S)-2,6- diaminohexanoic acid substance, 3-methyl-1,2,4-triazolyl-5-thioacetate, by absorption spectrophotometry in the ultraviolet region.

Methods: For study purposes, the substance (S)-2,6-diaminohexanoic acid of 3-methyl-1,2,4-triazolyl-5-thioacetate and a standard sample (SS) obtained from the State Enterprise Chemical Reagents Plant†of the Scientific-Technological Complex Institute of Single Crystals†of the National Academy of Sciences of Ukraine, was used. In the course of our work, we used chemical, physical, physicochemical (absorption spectrophotometry in the ultraviolet region), and statistical methods of analysis. The study was carried out at the Laboratory for Standardization and Technology of Medicines at the Department of Pharmaceutical Chemistry at the Zaporizhia State Medical University (Ukraine).

Results: In previous studies, we have developed a technique for spectrophotometric determination of the quantitative composition of (S)-2,6- diaminohexanoic acid of 3-methyl-1,2,4-triazolyl-5-thioacetate. The results of the conducted studies showed that the absorption curve in the UV region of the substance solution has a maximum absorption, namely: λ = 238 nm. The results of the quantitation of the substance (S)-2,6-diaminohexanoic acid of 3-methyl-1,2,4-triazolyl-5-thioacetate prove that our technique is accurate and reproducible and meets the current requirements. In order for the developed methodology to ensure consistent and accurate analysis results, its validation was carried out. According to the requirements of the State Pharmacopoeia of Ukraine (DFU) (2 editions), the developed method for the quantitation of the substance was checked for such validation characteristics as specificity, linearity, range of use, accuracy, correctness, and robustness.

Conclusion: As a result of the work, it was proved that the developed method of the quantitation of the substance (S)-2,6-diaminohexanoic acid of 3-methyl-1,2,4-triazolyl-5-thioacetate by spectrophotometric method is valid.

Downloads

Download data is not yet available.

Author Biography

Kucherenko Lyudmila Ivanovna, Department of Pharmaceutical Chemistry, Zaporizhia State Medical University, Zaporizhia, Ukraine

Pharmaceutical chemistry department, Candidate of Pharmaceutical Sciences

References

Sundström J, Arima H, Woodward M, Neal B. Blood pressure-lowering treatment based on cardiovascular risk: A meta analysis of individual patient data. Lancet 2014;384:591-8.

White W. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. New Jersey: Humana Press; 2001.

Mazur I, Chekman I, Belenichev I. Metabolithotropic Drugs. Ukraine: Zaporozhye; 2007.

Kucherenko LI, Khromylova OV, Moriak ZB, Tkachenko GI, Vaschenko OV. Stage control of tablets manufacturing. Aktualnipytanniafarmatsevtychnoi i Medychnoinaukytapraktyky 2014;2:31-4.

Mazur IA, Belenichev IF, Kucherenko LI, Georgievskij GV, Chekman IS, Buchtiyarova TA, et al. Approaches to the Development and Creation of Metabolitotropnyh Drugs-Derivatives of 1,2,4-Triazole. Gurzuf: Proceedings of the 12th Scientific and Practical Seminar; 2012.

Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines. State Pharmacopoeia of Ukraine. 2nd ed., Vol. 1. Kharkiv: Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines, Ukrainian; 2015. p. 85-100.

Beckett AH, Stenlake JB. UV-Visible Spectrophotometry: Practical Pharmaceutical Chemistry. 4th ed., vol. 2. New Delhi: C.B.S. Publishers; 2001. p. 285-97.

Kucherenko L. On the standardization of hypertril substance. Pharm Rev 2015;2:64-7.

Manjunath S, Chouhan V, Sandeep S. Spectrophotometric estimation of levosulpiride in bulk drug and formulations. Int J Pharm Pharm Sci 2011;3:135-7.

Nayak SC, Kulkarni PV, Bhaskar V, Chavhan V. Development and validation of UV spectrophotometric method for simultaneous estimation of aceclofenac and pantoprazole in bulk and tablet dosage forms using hydrotropic solvent. Int J Pharm Pharm Sci 2013;5:390-3.

Published

07-09-2018

How to Cite

Ivanovna, K. L., B. O. SERGEEVICH, and K. O. Vladimirovna. “VALIDATION OF THE SPECTROFOTOMETRIC METHOD FOR THE DETERMINATION OF QUANTITATIVE COMPOSITION OF S-2,6-DIAGENOXIC ACID OF 3-METHYL-1,2,4-TRIAZOLYL- 5-THIOACETATE”. Asian Journal of Pharmaceutical and Clinical Research, vol. 11, no. 9, Sept. 2018, pp. 91-94, doi:10.22159/ajpcr.2018.v11i9.26684.

Issue

Section

Original Article(s)